Plasma cytokines and oxidative damage in HIV-positive and HIV-negative adolescents and young adults: A protective role for IL-10?

Free Radical Research

Volumn 39, Issue 8, 2005, Pages 859-864

  Stephensen, Charles B ^a   Marquis, Grace S ^b   Douglas, Steven D ^c   Wilson, Craig M ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

HIV; IL 10; Malondialdehyde; Oxidative damage; Protein carbonyl

Indexed keywords

CYTOKINE; INTERLEUKIN 10;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CYTOKINES; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERLEUKIN-10; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS;

EID: 22144442472     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760500164136     Document Type: Review

References (14)

1. Ameglio F, Cordiali Fei P, Solmone M, Bonifati C, Prignano G, Giglio A, Caprilli F, Gentili G, Capobianchi MR. Serum IL-10 levels in HIV-positive subjects: Correlation with CDC stages. J Biol Regul Homeost Agents 1994;8:48-52.
2. Breen EC. Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol Ther 2002;95:295-304.
3. Carbonneil C, Donkova-Petrini V, Aouba A, Weiss L. Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: Neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha. J Immunol 2004;172:7832-7840.
4. Davis DW, Hamilton RF, Jr, Holian A. 4-Hydroxynonenal inhibits interleukin-1 beta converting enzyme. J Interferon Cytokine Res 1997;17:205-210.
5. Haddad JJ, Fahlman CS. Redox- and oxidant-mediated regulation of interleukin-10: An anti-inflammatory, antioxidant cytokine? Biochem Biophys Res Commun 2002;297:163-176.
6. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. New York: Oxford University Press; 1999.
7. Kruzich LA, Marquis GS, Carriquiry AI, Wilson CM, Stephensen CB. US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function. J Am Diet Assoc 2004;104:1095-1101.
8. Nakamura H, Masutani H, Yodoi J. Redox imbalance and its control in HIV infection. Antioxid Redox Signal 2002;4:455-464.
9. Rogers AS, Futterman DK, Moscicki AB, Wilson CM, Ellenberg J, Vermund SH. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, methods, and selected characteristics of participants. J Adolesc Health 1998;22:300-311.
10. Stephensen CB, Marquis GS, Douglas SD, Wilson CM. Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents. J Acquir Immune Defic Syndr 2005;38:180-190.
11. Stylianou E, Aukrust P, Kvale D, Muller F, Froland SS. IL- 10 in HIV infection: Increasing serum IL-10 levels with disease progression - down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol 1999;116:115-120.
12. Wilson CM, Ellenberg JH, Douglas SD, Moscicki AB, Holland CA. CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population. AIDS Res Hum Retroviruses 2004;20:263-269.
13. Wilson CM, Houser J, Partlow C, Rudy BJ, Futterman DC, Friedman LB. The REACH (Reaching for Excellence in Adolescent Care and Health) project: Study design, methods, and population profile. J Adolesc Health 2001;29:8-18.
14. Wykretowicz A, Furmaniuk J, Smielecki J, Deskur-Smielecka E, Szczepanik A, Banaszak A, Wysocki H. The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure. Int J Cardiol 2004;94:283-287.